Back
ESC Premium Access

Frequency, management and outcomes of patients with stable coronary artery disease eligible for COMPASS. An analysis of the CLARIFY registry.

Session: Antithrombotic therapy for coronary artery disease: opportunities and challenges
Topic: Epidemiology, Prognosis, Outcome
Speaker: Doctor E. Sorbets (Paris, FR)
Event: ESC Congress 2019

Congress Presentation

About the speaker

Doctor Emmanuel Sorbets

Hospital Hotel-Dieu, Paris (France)
3 presentations
0 follower

3 more presentations in this session

State of the Art - New options in antithrombotic therapy for coronary artery disease

Speaker: Professor K. Newby (Durham, US)

Access
Slides
Video
Thumbnail

Atherothrombotic risk and outcomes following guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome:a post-hoc analysis of the TROPICAL-ACS trial

Speaker: Assistant Professor K. Rizas (Tuebingen, DE)

Access
Abstract
Slides
Video
Thumbnail

Secondary prevention in 2030: will antiplatelets or anticoagulants prevail?

Speaker: Professor D. Angiolillo (Jacksonville, US)

Access
Slides
Video
Thumbnail

Access the full session

Antithrombotic therapy for coronary artery disease: opportunities and challenges

Speakers: Doctor E. Sorbets, Professor K. Newby, Assistant Professor K. Rizas, Professor D. Angiolillo
Access
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb